Carregant...
Anti PD-1 and Anti PD-L1 Monoclonal Antibodies in People Living with HIV and Cancer
PURPOSE OF REVIEW: Immune checkpoint inhibitors targeting the programmed cell death-1 (PD-1) pathway are a class of anti-cancer immunotherapy agents changing treatment paradigms of many cancers that occur at higher rates in people living with HIV (PLWH) than in the general population. However, PLWH...
Guardat en:
| Publicat a: | Curr HIV/AIDS Rep |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7799392/ https://ncbi.nlm.nih.gov/pubmed/32827111 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11904-020-00525-y |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|